ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: MSK Opens Campaign On Colorectal Cancer Early Detection NIH Symposium Dedicates Cyclotron

August 28, 1987

NCI Test Panels Available For Marker Evaluation

March 2, 1984

DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D

June 15, 1990

CCOP Success Acknowledged, Recompetition Plans Being Made; Cancer Control May Be Added To RFA

April 11, 1986

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

President’s Budget: $64 Million Cut for NCI, No Start On Year 2000 goals, Drop 240 Grants In 1985

February 8, 1985